Bell Potter Keeps Their Buy Rating on Pro Medicus Limited (PMCUF)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 27 2025
0mins
Should l Buy ?
Source: Business Insider
Analyst Ratings: Bell Potter analyst John Hester has maintained a Buy rating on Pro Medicus Limited (PMCUF) with a price target of A$280.00, while the current consensus is a Moderate Buy with an average price target of $175.16, indicating potential upside from its current share price of $126.03.
Insider Activity: Recent corporate insider activity shows positive sentiment towards Pro Medicus Limited, with an increase in insiders purchasing shares over the past quarter, reflecting confidence in the company's future performance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
